Opioids are a group of narcotic pain-relieving drug which act by interacting with opioid receptors in cells. Opioids can be made from the poppy plant such as, morphine or synthesized in a laboratory such as fentanyl. It is used as an anesthesia, cough suppressant, diarrhea suppressant and for the management of pain arising from various disease.
The opioids market is witnessing growth due to increasing prevalence of orthopedic diseases and chronic pain, rising focus on abuse-deterrent formulation (ADF), rising palliative care facilities, and inclination toward extended release formulations from the immediate release of opioids. However, factors such as prescription drug abuse, and legalization of cannabis as an alternative to opioids may hinder the growth of the market in the coming years.
The global opioids market is segmented on the basis of product, receptor binding, application, and region. On the basis of product, the market is divided into morphine, codeine, fentanyl, meperidine, methadone, and others. Based on the receptor binding, the market is segmented into strong agonist, and mild to moderate agonist. Based on application, the opioids market is classified into pain management, cough suppression, diarrhea suppression, and others. Based on region, the opioids market is segmented into the North America, Europe, Asia, and the Rest of the World (RoW).
This report is a comprehensive study of current trends in the market, industry growth drivers, and restraints. These markets are given analysis at regional level to provide exhaustive opioids market analysis for the years 2016, 2017, 2018, and forecast to 2023. Each market is comprehensively analyzed at a granular level by region (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.
The major players in the Infant nutrition market are Purdue Pharma (US), Sanofi (France), Pfizer (US), Janssen Pharmaceuticals (Belgium), Endo Pharmaceuticals, Inc (US), Actavis Plc (US), Egalet (US), Sun Pharmaceuticals (India), and Boehringer Ingelheim GmbH (Germany).
Table of Contents
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Considered for the Study
1.6 Market Stakeholders
2 Research Methodology
2.1 Secondary Data
2.2 Primary Data
2.3 Key Industry Insights
2.4 Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Market Share Estimation
2.7 Assumptions for the Study
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
6 Opioids Market, By Product
7 Opioids Market, By Receptor Binding
7.2 Strong Agonist
7.3 Mild to Moderate Agonist
8 Opioids Market, By Application
8.2 Pain Management
8.2.1 Cancer Pain
8.2.2 Neuropathic Pain
8.2.3 Osteoarthritis Pain
8.2.4 Other Pain Management
8.3 Cough Supression
8.4 Diarrhea Suppresion
9 Opioids Market, By Region
9.2 North America
9.3.6 Rest of Europe (RoE)
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 Agreements, Partnerships, and Collaborations
10.3.2 Product Launches and Upgrades
11 Company Profiles
(Overview, Financials, Products Offered, Recent Developments)*
11.1 Purdue Pharma
11.4 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
11.5 Endo Pharmaceuticals, Inc
11.6 Actavis PLC.
11.7 Mallinckrodt Pharmaceuticals
11.9 Boehringer Ingelheim GmbH
11.10 Sun Pharmaceuticals Industries, Inc
1 the List of Companies Mentioned Above is Indicative Only and Might Change During the Course of the Study. 10 Leading Companies in the Market Would Be Profiled.
2 Details on Financials Might Not Be Captured in Case of Privately Held Companies That Do Not Disclose Their Revenues in the Public Domain.
3 Years Considered for the Study Would Be Historical Year – 2016, Base Year – 2017, Estimated Year – 2018, Forecast Period – 2018 to 2023
4 the Market Tables Would Include Value Data in USD for the Years 2016, 2017, 2018 and Forecasted Value of 2023 Along With CAGR for the Period 2018-2023.